Jefferies Upgrades Questcor Pharmaceuticals (QCOR) to Buy, Sees Little Downside and Improved Visibility

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Jefferies Upgrades Questcor Pharmaceuticals (QCOR) to Buy, Sees Little Downside and Improved Visibility

Questcor's (QCOR) Acthar Sales See Month-over-Month Slide; Shares Higher on Upgrade

October 9, 2012 8:29 AM EDT

Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) disclosed in an 8-K filing this morning preliminary paid Acthar prescription data for September.

The company reported:
105-110 paid Acthar prescription for NS; down from 119 in August
400-410 paid Acthar prescription for MS;... More